Central Laboratories White Papers & Articles
-
Experts Discuss AI’s Future In Pharma
5/1/2024
At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.
-
Cancer Treatment: Advances In The 20th And 21st Centuries
4/29/2024
This exploration not only illuminates the remarkable strides made in combating cancer but also underscores the pivotal role of cutting-edge technologies in shaping the trajectory of oncological care.
-
6 Decades Of Impact: DIA’s Global Journey
4/29/2024
By embracing its foundational pillars, learn how DIA continues to address ongoing challenges in drug information and healthcare as it enters its seventh decade in the industry.
-
Empowering Transformation Through Technology
4/24/2024
By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.
-
4 Ways Concomitant Medications Can Complicate Your Trial
4/22/2024
Concomitant medications (con-meds) significantly influence clinical trials, affecting duration, costs, and participant safety. However, they are often inadequately tracked and analyzed in studies.
-
10 Reasons To Avoid Using Excel For Clinical Trials
4/22/2024
As clinical trials become increasingly complex and global, learn why abandoning Excel for specialized applications becomes imperative for efficiency, accuracy, and cost-effectiveness.
-
Understanding FDA’s 2024 Draft Guidance On DMCs
4/19/2024
By integrating independent Data Monitoring Committees into trial management processes, learn how sponsors can enhance trust, integrity, and the success of their clinical trials.
-
The Value Of Continuity: Program-Level DSMBs
4/19/2024
Discover the strategic benefits of deploying consistent DSMB members across therapeutic programs, highlighting the pivotal role of program-level supervision in safeguarding the safety and effectiveness of novel treatments.
-
Optimizing Generative AI In Clinical Operations
4/17/2024
Crafting a thoughtful strategy to determine the optimal utilization of Generative AI in advancing medical research and enhancing patient well-being.
-
2024 MedTech Regulatory Updates: 4 Areas Of Interest
4/15/2024
In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.